Akums Drugs and Pharmaceutical, an Indian contract drug manufacturing company (CDMO) has launched the novel antidiabetic drug ‘Lobeglitazone’, the drug is a new formulation manufactured specifically for type 2 diabetic patients by helping them improve pancreatic beta-cell function, the pharma company said in a statement on Monday
Read More
Chennai-based drug firm Global Pharma Healthcare is voluntarily recalling all lots within expiry of their Artificial Tears Lubricant Eye Drops, distributed by /EzriCare, LLC- and Delsam Pharma, to the consumer level, due to possible contamination, the USFDA on Thursday said in a statement
Read More
The drug, which is expected to be available in the United States in the coming weeks, aims to treat adults with mantle cell lymphoma after at least two lines of therapy. Mantle cell lymphoma is a rare type of blood cancer that starts in white blood cells in the lymph nodes and aggressively spreads to other parts of the body
Read More
Mumbai-based pharmaceutical company Glenmark on Friday said that its manufacturing facility in Baddi which was earlier kept under the import alert list by the USFDA in October 2022, will now be supplying Atovaquone Oral Suspension USP 750mg/5 to the US market as per the latest communication received by the company from the top US regulator
Read More
The manufacturing site was first inspected on September 28, 2022, and was issued Form 483 with three observations by the top US Health regulator flagging quality as well as procedural lapses at the facility
Read More
She says that India's presidency will aim to build on previous health working groups' and G20 leaders' efforts and proposals, such as strengthening our healthcare systems and prioritising one health
Read More
Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of Major Depressive Disorder (MDD) in adults
Read More
Zydus's Brexpiprazole is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults. It is also indicated for the treatment of schizophrenia in adults and pediatric patients ages 13 years and old
Read More
